Program

Music Centre, Kuopio, Finland | June 15–17, 2026

Day 1 – Monday, June 15, 2026

11:30- Registration, salad lunch available

13:00–14.00 Opening Ceremony & Welcome and History Remarks

13.00-13.20 Opening of the Symposium

Markus Forsberg, Dean of the Faculty of Health Science, University of Eastern Finland 

Antti Hedman, Chief Executive Medical Officer, Kuopio University Hospital, Welfare County of North Savo 

13.20–14.00 50 Years of Translational Neuroscience in Kuopio, Prof. Reetta Kälviäinen, Kuopio, Finland

14.00–15.30 Microglia-neuron interaction in brain diseases  

Chair Prof. Tarja Malm

14.00-14.30 A microglia’s cell fate in Alzheimer’s disease, Prof. Michael Heneka, Luxembourg

14.30-15.00 Microglia-neurovascular interactions: roles beyond inflammation in health and CNS disorders, Prof. Adam Denes, Budapest, Hungary

15.00-15.30 Neuro-glia-immune mechanisms of synapse loss, Prof. Soyon Hong, London, UK

15.30–16.00 Coffee & Poster Session I

16.00–17.30 Multimodal Imaging the Brain Diseases and AI-enhanced imaging biomarkers

Chair Prof. Alejandra Sierra Lopez

16.00-16.30 Current and future role of PET imaging in Alzheimer’s disease research and diagnostics, Prof. Michael Schöll, Gothenburg, Sweden

16.30-17.00 From Visual Reading to AI-driven Analytics in Neurodegenerative Diseases, Adjunct Prof. Valtteri Julkunen, Kuopio, Finland and Adjunct Prof. Jyrki Lötjönen, Tampere, Finland

17.00-17.30 Multiscale imaging of the brain, Prof. Alejandra Sierra Lopez, Kuopio, Finland

18.00-19.00 Symposium Reception at Kuopio City Hall (Tulliportinkatu 31, 70110 Kuopio)

Day 2 – Tuesday, June 16, 2026

08.30–10.30 From Genes to Therapy in Neurodegenerative diseases

Chair Prof. Mikko Hiltunen

08.30-09.00 Etiology of normal pressure hydrocephalus, Prof. Neill R Graff-Radford, Jacksonville, USA

09.00-09.30 Outcome of normal pressure hydrocephalus, Prof. Ville Leinonen, Kuopio, Finland

09.30-10.00 Early cortical changes in Alzheimer’s disease involve a temporary phase characterized by distinct cellular states, Prof. Evan Z Macosko, Boston, USA

10.00-10.30 Characterization of Alzheimer’s disease-associated genetic variants and mechanisms in normal pressure hydrocephalus patient samples, Prof. Mikko Hiltunen, Kuopio, Finland

10.30–11.00 Coffee Break & Poster Session II

11.00–13.00 Biomarkers and Disease Modification: A New Era of Precision Therapy

Chair Prof. Eino Solje

11.00-11.05 Opening remarks

11.05-11.25 From Past to Precision: Lessons from the History of Neurology, Prof. Katharina Bürger, Munchen, Germany

11.25-11.45 Fluid Biomarkers in Neurodegenerative Diseases: From Discovery to Clinical Application, Prof. Eino Solje, Kuopio, Finland

11.45-12.05 Alzheimer’s Disease Modification: The Current Landscape and Future Horizons, Prof. Kristian Steen Frederiksen, Copenhagen, Denmark

12.05-12.25 Targeting the mTOR Pathway: Disease Modification in Epilepsy, Tuberous Sclerosis and Beyond, Prof. Laura Mantoan-Ritter, London, UK

12.25-12.45 Precision Medicine in Frontotemporal Dementia: From Genes to Targeted Therapies, Prof. Yolande Pijnenburg, Amsterdam, Netherlands

12.45-13.00 general discussion with all speakers

13.00–14.00 Lunch

14.00–15.30 Towards more precise care of epilepsies

Chair Prof. Heikki Tanila

14.00-14.30 Gene Therapy in Epilepsy From Bench to Bedside, Prof. Matthew Walker, London, UK

14.30-15.00 Modern Epilepsy Surgery, Dr. Leena Jutila and Adjunct. Professor Arto Immonen Kuopio Epilepsy Surgery Team, Kuopio, Finland

15.00-15.30 Multimodal approach to characterize surgically removed epileptogenic zone: from operating room to wet lab, Prof. Alejandra Sierra Lopez and Prof. Tarja Malm, Kuopio, Finland

15.30–16.00 Coffee Break

16.00–17.30 How Do We Get From Bench to Public Policy?

16:00-16:20 Sirpa Pietikäinen 

Why Brain Health Matters for Europe

16:20-16:40 Kristian Steen Frederiksen

Investing in Brain Health – Industry, Innovation and International Cooperation

16:40-17:30 Panel discussion

Moderator: Eino Solje, Professor of Clinical Research, University of Eastern Finland

Panelists:

Sirpa Pietikäinen, Member of the European Parliament, Finland

Kristian Steen Frederiksen, Director of the Clinical Trial Unit, Danish Dementia Research Centre, Copenhagen

Reetta Kälviäinen, Professor of Neurology, University of Eastern Finland

Katariina Suomu, CEO, Finnish Alzheimer Association

Miia Kivipelto, Professor in Clinical Geriatrics, Karolinska Institutet

19.00– Symposium Dinner at Hotel Scandic Kuopio (Satamakatu 1, 70100 Kuopio)

Day 3 – Wednesday, June 17, 2026

08.30–10.00 The Changing Landscape of Stroke in Young Adults and Children

Chair Prof. Pekka Jäkälä

08.30-09.00 Emerging Insights into Risk Factors and Etiology of Ischemic Stroke in Young Adults, Prof. Jukka Putaala, Helsinki, Finland

09.00-09.30 Advances in the Diagnosis and Management of Cerebrovascular Disease in Children, Dr. Silva Lõo, Helsinki, Finland

09.30-10.00 Neuropathology and genetics of small vessel disease, Ass Prof. Liisa Myllykangas, Helsinki, Finland

10.00–10.30 Coffee Break & Poster Session III

10.30–12.30 Translating Brain Science Into Action: Mechanisms, Interventions, and Global Impact

Chair Prof. Alina Solomon

10.30-11.00 Dementia prevention from observation to action: innovative multimodal interventions in Finland and worldwide, Prof. Miia Kivipelto, Stockholm, Sweden

11.00-11.30 Mechanisms of multimodal lifestyle interventions, Ass Prof. Anna Matton, Stockholm, Sweden

11.30–12.00 Multinutrient intervention in Alzheimer’s disease: From synapse modulation to clinical trials, Prof. Tobias Hartmann, Saarbrücken, Germany

12.00-12.30 How does the air we breathe affect our brain health? Prof. Katja Kanninen, Kuopio, Finland

12.30–13.30 Lunch

13.30-15.00 Vision of the Future: From Research to Health Care Innovation

Chair and moderator: Director of the Neurocenter Finland, Eero Rissanen     

13.30-13.35 Opening Remarks, Eero Rissanen    

13.35-14.00 National Brain and Mind Flagship Concept, Prof. Mikko Hiltunen      

14.00 -14.25 Building the Foundation for the cross-boundary collaboration, Eero Rissanen                                     

14.30-15.00 Stakeholder Roundtable Discussion: Co-Creating Precision Neuroscience

15.00–15.30 Closing Ceremony & Farewell Address with afternoon snack